摘要 |
<p>It is intended to provide a novel monoclonal antibody having a binding specificity to GALP or its derivative, which is useful in developing remedies, preventives and diagnostics for diseases in which GALP or its derivative participates, and a method of quantifying GALP using the antibody. More specifically, an antibody specifically reacting with a C-terminal peptide fragment of a polypeptide having an amino acid sequence represented by any of SEQ ID NOS:1 to 3 or its derivative, and a method of quantifying GALP or its derivative with the use of the antibody are provided.</p> |